ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Cannabist Company Holdings Inc

Cannabist Company Holdings Inc (CBST)

0,08
0,005
( 6,67% )
Aktualisiert: 17:51:57
Echtzeitdaten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,08
Gebot
0,075
Fragen
0,08
Volumen
948.031
0,07 Tagesbereich 0,08
0,0675 52-Wochen-Bereich 0,83
Handelsende
0,075
Handelsbeginn
0,08
Letzte Trade
1000
@
0.08
Letzter Handelszeitpunkt
17:51:03
Durchschnittliches Volumen (3 Mio.)
714.634
Finanzvolumen
-
VWAP
-

CBST Neueste Nachrichten

Verano Announces Closing of Acquisition of Arizona and Virginia Subsidiaries of The Cannabist Company, Becomes Exclusive Cannabis Operator for HSA 5 in Eastern Virginia and Strengthens Arizona Footprint

Acquisitions Expand Verano’s Footprint to 14 States, 15 Cultivation and Production Facilities, and 150 Dispensaries Nationwide CHICAGO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Verano Holdings Corp...

Dana Holding Set to Join the S&P MidCap 400

Dana Holding Set to Join the S&P MidCap 400 PR Newswire NEW YORK, Jan. 20, 2015 NEW YORK, Jan. 20, 2015 /PRNewswire/ -- Dana Holding Corp. (NYSE: DAN) will replace Cubist Pharmaceuticals Inc...

Cubist Announces Withdrawal of Listing of CVRs (CBSTZ) from NASDAQ Global Select Market

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will voluntarily withdraw the contingent value rights (CVRs) it issued under a Contingent Value Rights Agreement dated...

Cubist meldet FDA-Zulassung seines neuen Antibiotikums ZERBAXA™ (Ceftolozan/Tazobactam) für komplizierte Harnwegsinfektion...

ZERBAXA geht bestimmte gefährliche und resistente gramnegative Bakterien anErstes in den USA unter dem GAIN-Gesetz zugelassenes Antibiotikum gegen gramnegative Bakterien Cubist...

Cubist annonce l’approbation par la FDA du nouvel antibiotique ZERBAXA™ (ceftolozane/tazobactam) pour le traitement des i...

ZERBAXA s’attaque à certaines bactéries à Gram négatif graves et résistantes Premier nouvel antibiotique approuvé aux États-Unis dans le cadre de la GAIN Act pour le traitement des...

Cubist Announces FDA Approval of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) for Complicated Urinary Tract & Complicat...

ZERBAXA addresses certain serious and resistant Gram-negative bacteriaFirst new antibiotic approved in U.S. under the GAIN Act that treats Gram-negative bacteria Cubist...

Merck Begins Tender Offer to Acquire Cubist

Merck (NYSE:MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender to purchase all outstanding shares of common stock of Cubist...

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. R...

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company PR Newswire BALA...

CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over ...

CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Merck & Co. Inc...

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Cubist Pharmaceuticals, Inc. And Encourag...

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.080.090.067512316630.075CS
4-0.075-48.38709677420.1550.1550.06758310360.0863655CS
12-0.215-72.88135593220.2950.3550.06757146340.16190136CS
26-0.185-69.81132075470.2650.420.06755546210.22778952CS
52-0.49-85.96491228070.570.830.067510145020.43525513CS
156-1.6-95.23809523811.681.760.067510743130.54258874CS
260-1.6-95.23809523811.681.760.067510743130.54258874CS

CBST - Frequently Asked Questions (FAQ)

What is the current Cannabist share price?
The current share price of Cannabist is $ 0,08
What is the 1 year trading range for Cannabist share price?
Cannabist has traded in the range of $ 0,0675 to $ 0,83 during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
VERSVerses AI Inc
$ 1,48
(20,33%)
1,22M
BTQBTQ Technologies Corp
$ 3,94
(7,65%)
456,47k
CBSTCannabist Company Holdings Inc
$ 0,08
(6,67%)
948,03k
HOLDImmutable Holdings Inc
$ 0,105
(5,00%)
17,76k
JET.BGlobal Crossing Airlines Group Inc
$ 0,60
(1,69%)
5,52k
IFSSInterfield Global Software Inc
$ 0,02
(-42,86%)
6,22k
FHFilament Health Corp
$ 0,03
(-14,29%)
3k
CDMNCanadian Manganese Company Inc
$ 0,035
(-12,50%)
132,99k
GRAMGold Flora Corporation
$ 0,04
(-11,11%)
39,42k
NETZCarbon Streaming Corporation WTS B
$ 0,49
(-10,91%)
41,4k
VERSVerses AI Inc
$ 1,48
(20,33%)
1,22M
CBSTCannabist Company Holdings Inc
$ 0,08
(6,67%)
948,03k
BTQBTQ Technologies Corp
$ 3,94
(7,65%)
456,47k
DEFIValour Inc
$ 3,80
(-7,32%)
377,64k
BCBNBase Carbon Inc
$ 0,42
(1,20%)
155,2k
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock